NEW YORK, March 27, 2018 -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of Illinois on behalf of investors who purchased Akorn, Inc. ("Akorn") (NASDAQ:AKRX) securities between March 1, 2017 and February 26, 2018.
Click here to learn about the case: http://www.wongesq.com/pslra-c/akorn-inc?wire=3. There is no cost or obligation to you.
According to the complaint, throughout the Class Period, the Company issued materially false and misleading statements and/or failed to disclose that: (1) the Company’s failure to comply with FDA data integrity requirements would jeopardize Fresenius’ acquisition of the Company; (2) the Company lacked effective internal controls over financial reporting; and (3) as a result, the Company’s financial statements were materially false and misleading at all relevant times.
If you suffered a loss in Akorn you have until May 7, 2018 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra-c/akorn-inc?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]


Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook
Shein Targets $30B-$40B Valuation in Hong Kong IPO Planned for August
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Bayer Q2 Earnings Beat Forecasts as Crop Science Boosts Results, Debt Outlook Improves
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
SK Hynix Bonus Dispute Deepens as Union Rejects Stock-Based Payout Proposal
Meta Cuts Wipro Outsourcing by 25% After AI-Led Restructuring
Samsung, SK Hynix Test AMEC Chipmaking Tools for China Backup Plan
Toyota Raises FY2027 Outlook, Announces ¥1 Trillion Buyback Despite Q1 Profit Dip
FleetPartners Shares Jump After A$760 Million Takeover Proposal From Pacific Equity Partners
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
BHP Port Hedland Strike Set to Proceed as Wage Talks Continue 



